← Back to Search

TRIP Patient Navigation Intervention for Breast Cancer (TRIP Trial)

N/A
Waitlist Available
Led By Tracy Battaglia, MD., MPH
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 365 days of enrollment
Awards & highlights

TRIP Trial Summary

This trial aims to help minority and low-income women with breast cancer in Boston by creating regional patient registries, screening for social barriers to care, and providing patient navigation services.

Eligible Conditions
  • Breast Cancer

TRIP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 365 days of enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 365 days of enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time-to-treatment post-diagnosis

TRIP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TRIP Patient Navigation InterventionExperimental Treatment1 Intervention
This study will be enhancing current patient navigation at the participating 6 hospitals with the 3 components of the TRIP intervention (a shared patient registry, a social determinants of health platform, and additional training and support for Patient Navigators). All patients that are identified as TRIP eligible will receive these intervention benefits and will be categorized into the experimental arm of the study.
Group II: Historical ControlActive Control1 Intervention
This study will be utilizing electronic health record data to identify patients that match the TRIP eligibility criteria and received patient navigation prior to study rollout in June 2018. These patients will receive standard patient navigation at their care site and will act as historical controls in comparison to the TRIP experimental group.

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterOTHER
836 Previous Clinical Trials
13,008,596 Total Patients Enrolled
47 Trials studying Breast Cancer
5,533 Patients Enrolled for Breast Cancer
Tufts Medical CenterOTHER
252 Previous Clinical Trials
251,282 Total Patients Enrolled
4 Trials studying Breast Cancer
126 Patients Enrolled for Breast Cancer
Dana-Farber Cancer InstituteOTHER
1,078 Previous Clinical Trials
339,140 Total Patients Enrolled
141 Trials studying Breast Cancer
20,885 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are additional participants being sought for this research endeavor?

"Clinicaltrials.gov reveals that, as of July 29th 2022, this trial is not enrolling participants any longer. Although the original posting was on August 6th 2018, more than 2600 other trials are actively recruiting patients now."

Answered by AI
Recent research and studies
~260 spots leftby Apr 2025